ANDA 70184, held by Teva Pharmaceutical Industries. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 70184 (Metoclopramide Hydrochloride), held by Teva Pharmaceutical Industries, was first approved by FDA on Jul 29, 1985, with 43 approved supplements and 0 published complete response letters.
Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. Relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Limitations of Use: Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 29, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 10MG BASE · tablet;oral | Metoclopramide Hydrochloride | Rx |
| Jul 16, 2019 | Supplement 69Labeling · Standard review | Approved | None posted |
| Dec 10, 2014 | Supplement 66Labeling | Approved | None posted |
| Jul 28, 2014 | Supplement 61Manufacturing | Approved | None posted |
| Feb 28, 2011 | Supplement 63Labeling | Approved | None posted |
| Mar 31, 2010 | Supplement 62REMS | Approved | None posted |
| Nov 16, 2009 | Supplement 60Labeling | Approved | None posted |
| Jan 17, 2007 | Supplement 55Labeling | Approved | None posted |
| Aug 12, 2002 | Supplement 44Labeling | Approved | None posted |
| Nov 13, 2001 | Supplement 43Manufacturing | Approved | None posted |
| Oct 24, 2001 | Supplement 42Manufacturing | Approved | None posted |
| Jan 29, 2001 | Supplement 41Labeling | Approved | None posted |
| Jul 7, 2000 | Supplement 40Manufacturing | Approved | None posted |
| Jan 27, 2000 | Supplement 37Manufacturing | Approved | None posted |
| Dec 22, 1999 | Supplement 39Labeling | Approved | None posted |
| Oct 27, 1999 | Supplement 38Labeling | Approved | None posted |
| Mar 26, 1999 | Supplement 36Manufacturing | Approved | None posted |
| May 20, 1998 | Supplement 35Manufacturing | Approved | None posted |
| Jun 18, 1997 | Supplement 34Manufacturing | Approved | None posted |
| Mar 11, 1996 | Supplement 33Labeling | Approved | None posted |
| Feb 17, 1995 | Supplement 32Manufacturing | Approved | None posted |
| Feb 16, 1995 | Supplement 30Manufacturing | Approved | None posted |
| Oct 20, 1994 | Supplement 28Manufacturing | Approved | None posted |
| Sep 6, 1994 | Supplement 29Manufacturing | Approved | None posted |
| Jun 17, 1994 | Supplement 27Manufacturing | Approved | None posted |
| Mar 10, 1994 | Supplement 26Labeling | Approved | None posted |
| Sep 21, 1993 | Supplement 25Labeling | Approved | None posted |
| Aug 5, 1993 | Supplement 18Manufacturing | Approved | None posted |
| Mar 18, 1993 | Supplement 24Labeling | Approved | None posted |
| Jun 17, 1992 | Supplement 23Labeling | Approved | None posted |
| Mar 12, 1991 | Supplement 22Labeling | Approved | None posted |
| Sep 6, 1990 | Supplement 19Labeling | Approved | None posted |
| Mar 16, 1989 | Supplement 10Manufacturing | Approved | None posted |
| Dec 16, 1988 | Supplement 17Labeling | Approved | None posted |
| Dec 6, 1988 | Supplement 16Labeling | Approved | None posted |
| Sep 23, 1988 | Supplement 15Manufacturing | Approved | None posted |
| Oct 26, 1987 | Supplement 12Manufacturing | Approved | None posted |
| Mar 9, 1987 | Supplement 9Manufacturing | Approved | None posted |
| Nov 5, 1986 | Supplement 8Manufacturing | Approved | None posted |
| Nov 5, 1986 | Supplement 6Manufacturing | Approved | None posted |
| Nov 5, 1986 | Supplement 5Manufacturing | Approved | None posted |
| Nov 5, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Feb 26, 1986 | Supplement 4Manufacturing | Approved | None posted |
| Feb 26, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Jul 29, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters